Have noted that the founder of Chinese Pioneer Pharma Holdings (Paul Xinzhou Li) was a director of Paragon from January 2021 until September 2021, probably being part of the time when they were invested in Paragon Care. They must have sold out at a considerable loss considering their entry price, and when they sold.
Quite intriguing that they have once again made a substantial investment in Paragon only a few years after selling out.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
-0.005(1.25%) |
Mkt cap ! $653.8M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 39.0¢ | $53.64K | 134.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 7669 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 58867 | 2 |
View Market Depth
| Last trade - 12.43pm 17/06/2025 (20 minute delay) ? |
| PGC (ASX) Chart |